George A. Komatsoulis, PhD, Joins CancerLinQ LLC as Chief of Bio-Informatics
George A. Komatsoulis, PhD
CancerLinQ LLC has announced that George A. Komatsoulis, PhD, will be its first Chief of Bio-Informatics. This marks another step toward the organization’s goal of making the CancerLinQ® platform the premier system for unlocking patient data from millions of electronic health records, breaking down silos among various electronic health records systems and providers, and securely processing and analyzing the data to give personalized insights that can improve the quality of care for patients with cancer.
“With more than 1.5 million records in the system and more being inputted every day, the CancerLinQ platform is now in a position to analyze and discover insights and trends that can improve cancer care,” said CancerLinQ LLC Chief Executive Officer Kevin Fitzpatrick. “We are excited to have Dr. Komatsoulis joining the CancerLinQ team to lead this effort that is vital to improving cancer care.”
Dr. Komatsoulis will serve in this new role and joins ASCO after more than 20 years of experience in the fields of information technology and biomedical informatics. Prior to joining the CancerLinQ team, he spent 12 years in senior positions at the National Institutes of Health (NIH). During that time, he served as Deputy and Interim Director of the National Cancer Institute (NCI) Center for Biomedical Informatics and Information Technology, Chief Information Officer at the NCI, and Acting Chief of the Informatics Resources Branch at the National Center for Biotechnology Information.
Dr. Komatsoulis’ work at the NIH focused on bringing advanced information technology capabilities to the biomedical research community, most recently cloud computing via the NCI’s Cancer Genomics Cloud Pilots and the NIH Commons Credits Model programs. He also has experience in the commercial sector in the Bioinformatics Department at Human Genome Sciences, Inc.
Dr. Komatsoulis holds a PhD in molecular biology and biochemistry from the California Institute of Technology and a BS in microbiology from Cornell University.
CancerLinQ is a powerful platform containing growing amounts of real-world cancer information. This national initiative will allow cancer providers to improve the quality and value of care by analyzing millions of cancer patient medical records, uncovering patterns and trends, and measuring their care against that of their peers and recommended guidelines.
Earlier this year, ASCO announced that CancerLinQ had more than 1 million patient records in its system, as well as more than 70 practices that had signed agreements to participate, representing more than 1,500 oncologists. ■